Conjugate Vaccines: Practice and Theory

Overview

Journal Springer Semin Immunopathol

Specialty Allergy & Immunology

Date 1993 Jan 1

PMID 8256199

Citations 3

Authors

R S Becker

Affiliations

Soon will be listed here.

Citing Articles

Synthesis, characterization and immunological properties of Escherichia coli 0157:H7 lipopolysaccharide- diphtheria toxoid conjugate vaccine.

Rokhsartalab-Azar S, Shapouri R, Rahnema M, Najafzadeh F, Kianmehr A Iran J Microbiol. 2015; 7(3):150-5.

PMID: 26668702 PMC: 4676984.

Use of licensed vaccines for active immunization of the immunocompromised host.

Pirofski L, Casadevall A Clin Microbiol Rev. 1998; 11(1):1-26.

PMID: 9457426 PMC: 121373. DOI: 10.1128/CMR.11.1.1.

Role of the capsular polysaccharide-like serotype-specific antigen in resistance of Actinobacillus actinomycetemcomitans to phagocytosis by human polymorphonuclear leukocytes.

Yamaguchi N, Kawasaki M, Yamashita Y, Nakashima K, Koga T Infect Immun. 1995; 63(12):4589-94.

PMID: 7591110 PMC: 173659. DOI: 10.1128/iai.63.12.4589-4594.1995.

References

Noel G, Katz S, Edelson P . Complement-mediated early clearance of Haemophilus influenzae type b from blood is independent of serum lytic activity. J Infect Dis. 1988; 157(1):85-90. DOI: 10.1093/infdis/157.1.85. View

Eynon E, Parker D . Small B cells as antigen-presenting cells in the induction of tolerance to soluble protein antigens. J Exp Med. 1992; 175(1):131-8. PMC: 2119092. DOI: 10.1084/jem.175.1.131. View

Tam J . High-density multiple antigen-peptide system for preparation of antipeptide antibodies. Methods Enzymol. 1989; 168:7-15. DOI: 10.1016/0076-6879(89)68004-4. View

Donnelly J, Deck R, Liu M . Immunogenicity of a Haemophilus influenzae polysaccharide-Neisseria meningitidis outer membrane protein complex conjugate vaccine. J Immunol. 1990; 145(9):3071-9. View

Santosham M, Wolff M, Reid R, Hohenboken M, BATEMAN M, Goepp J . The efficacy in Navajo infants of a conjugate vaccine consisting of Haemophilus influenzae type b polysaccharide and Neisseria meningitidis outer-membrane protein complex. N Engl J Med. 1991; 324(25):1767-72. DOI: 10.1056/NEJM199106203242503. View

Lambris J . The multifunctional role of C3, the third component of complement. Immunol Today. 1988; 9(12):387-93. DOI: 10.1016/0167-5699(88)91240-6. View

McCarthy P, Grundy G, Spiesel S, Dolan Jr T . Bacteremia in children: an outpatient clinical review. Pediatrics. 1976; 57(6):861-8. View

Claesson B, Trollfors B, Lagergard T, TARANGER J, Bryla D, Otterman G . Clinical and immunologic responses to the capsular polysaccharide of Haemophilus influenzae type b alone or conjugated to tetanus toxoid in 18- to 23-month-old children. J Pediatr. 1988; 112(5):695-702. DOI: 10.1016/s0022-3476(88)80684-x. View

Adderson E, Shackelford P, Insel R, Quinn A, Wilson P, Carroll W . Immunoglobulin light chain variable region gene sequences for human antibodies to Haemophilus influenzae type b capsular polysaccharide are dominated by a limited number of V kappa and V lambda segments and VJ combinations. J Clin Invest. 1992; 89(3):729-38. PMC: 442915. DOI: 10.1172/JCI115649. View

10.

Adderson E, Shackelford P, Quinn A, Carroll W . Restricted Ig H chain V gene usage in the human antibody response to Haemophilus influenzae type b capsular polysaccharide. J Immunol. 1991; 147(5):1667-74. View

11.

AVERY O, GOEBEL W . CHEMO-IMMUNOLOGICAL STUDIES ON CONJUGATED CARBOHYDRATE-PROTEINS : II. IMMUNOLOGICAL SPECIFICITY OF SYNTHETIC SUGAR-PROTEIN ANTIGENS. J Exp Med. 2009; 50(4):533-50. PMC: 2131643. DOI: 10.1084/jem.50.4.533. View

12.

Granoff D, Weinberg G, Shackelford P . IgG subclass response to immunization with Haemophilus influenzae type b polysaccharide-outer membrane protein conjugate vaccine. Pediatr Res. 1988; 24(2):180-5. DOI: 10.1203/00006450-198808000-00008. View

13.

Wirbelauer C, Meding S, Stockinger B, Gillard S, Langhorne J . Analysis of T lymphocyte reactivity to complex antigen mixtures by the use of proteins coupled to latex beads. Immunol Lett. 1990; 23(4):257-62. DOI: 10.1016/0165-2478(90)90069-3. View

14.

Peltola H, Kayhty H, Sivonen A, Makela H . Haemophilus influenzae type b capsular polysaccharide vaccine in children: a double-blind field study of 100,000 vaccinees 3 months to 5 years of age in Finland. Pediatrics. 1977; 60(5):730-7. View

15.

Tam J . Synthetic peptide vaccine design: synthesis and properties of a high-density multiple antigenic peptide system. Proc Natl Acad Sci U S A. 1988; 85(15):5409-13. PMC: 281766. DOI: 10.1073/pnas.85.15.5409. View

16.

Decker M, Edwards K, Bradley R, Palmer P . Comparative trial in infants of four conjugate Haemophilus influenzae type b vaccines. J Pediatr. 1992; 120(2 Pt 1):184-9. DOI: 10.1016/s0022-3476(05)80424-x. View

17.

Singer A, Hodes R . Mechanisms of T cell-B cell interaction. Annu Rev Immunol. 1983; 1:211-41. DOI: 10.1146/annurev.iy.01.040183.001235. View

18.

Scott M, Nahm M . Characterization of the human IgG antibody VL repertoire to Haemophilus influenzae type b polysaccharide. J Infect Dis. 1992; 165 Suppl 1:S53-6. DOI: 10.1093/infdis/165-supplement_1-s53. View

19.

Barington T, Heilmann C . An improved haemolytic plaque assay for the detection of cells secreting antibody to bacterial antigens. J Immunol Methods. 1992; 146(1):129-37. DOI: 10.1016/0022-1759(92)90056-y. View

20.

Schutze M, Leclerc C, Jolivet M, Audibert F, CHEDID L . Carrier-induced epitopic suppression, a major issue for future synthetic vaccines. J Immunol. 1985; 135(4):2319-22. View